Scientists track genetic shifts in returning breast cancer
NCT ID NCT02530008
First seen Jan 22, 2026 · Last updated May 21, 2026 · Updated 17 times
Summary
This study follows 600 women whose breast cancer has returned after initial treatment. Researchers collect tumor samples and blood to track genetic changes over time. The goal is to learn how the cancer evolves, not to test a new treatment. Participants must be willing to have biopsies and blood draws at multiple time points.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOMEN WITH SUSPECTED OR CONFIRMED RECURRENT BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
Conditions
Explore the condition pages connected to this study.